476 related articles for article (PubMed ID: 30542738)
21. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
22. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
24. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
Zheng Z; Chen M; Xing P; Yan X; Xie B
Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MITA1 promotes gefitinib resistance by inducing autophagy in lung cancer cells.
Hu J; Dong SW; Pei Y; Wang J; Zhang J; Wei XP
Biochem Biophys Res Commun; 2021 Apr; 551():21-26. PubMed ID: 33714755
[TBL] [Abstract][Full Text] [Related]
26. Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer.
Deng Q; Fang Q; Xie B; Sun H; Bao Y; Zhou S
Aging (Albany NY); 2020 May; 12(9):8001-8015. PubMed ID: 32375124
[TBL] [Abstract][Full Text] [Related]
27. The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting
Wang Z; Pan L; Yu H; Wang Y
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29592872
[TBL] [Abstract][Full Text] [Related]
28. Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis.
Yu B; Zheng L; Tang H; Wang W; Lin Y
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396444
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.
Hu Y; Qin X; Yan D; Cao H; Zhou L; Fan F; Zang J; Ni J; Xu X; Sha H; Liu S; Yu S; Wu J; Ma R; Feng J
Tumour Biol; 2017 Mar; 39(3):1010428317691659. PubMed ID: 28345454
[TBL] [Abstract][Full Text] [Related]
30. The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC.
Li X; Zhang X; Yang C; Cui S; Shen Q; Xu S
Cell Cycle; 2018; 17(14):1772-1783. PubMed ID: 30010468
[TBL] [Abstract][Full Text] [Related]
31. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer.
Shan KZ; Yang SF; Deng YJ; Yue PY; Du ZQ
Acta Biochim Pol; 2022 Oct; 69(4):795-804. PubMed ID: 36257058
[TBL] [Abstract][Full Text] [Related]
32. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
33. Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer.
Wang X; Pei X; Guo G; Qian X; Dou D; Zhang Z; Xu X; Duan X
J Cell Physiol; 2020 Oct; 235(10):6896-6904. PubMed ID: 31994191
[TBL] [Abstract][Full Text] [Related]
34. FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop.
Bing Z; Han J; Zheng Z; Liang N
Life Sci; 2021 Dec; 287():120012. PubMed ID: 34619168
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
[TBL] [Abstract][Full Text] [Related]
36. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MALAT1 Promotes Lung Cancer Proliferation and Gefitinib Resistance by Acting as a miR-200a Sponge.
Feng C; Zhao Y; Li Y; Zhang T; Ma Y; Liu Y
Arch Bronconeumol (Engl Ed); 2019 Dec; 55(12):627-633. PubMed ID: 31133357
[TBL] [Abstract][Full Text] [Related]
38. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancer.
Pan H; Jiang T; Cheng N; Wang Q; Ren S; Li X; Zhao C; Zhang L; Cai W; Zhou C
Oncotarget; 2016 Aug; 7(31):49948-49960. PubMed ID: 27409677
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of LncRNAH19 has the effect of anti-tumour and enhancing sensitivity to Gefitinib and Chemotherapy in Non-small-cell lung cancer in vivo.
Zhou Y; Zhang Y
J Cell Mol Med; 2020 May; 24(10):5811-5816. PubMed ID: 32281297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
